Drug
Glycopyrronium Bromide
Glycopyrronium Bromide: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Glycopyrronium Bromide NCT04320342 | Phase 3 | COPD |
Latest
No recent events.
Follow Glycopyrronium Bromide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.